BHVN - Biohaven Ltd.

QQQ $ 452.83 $ 6.97 (1.56 %)

DIA $ 399.31 $ 3.70 (0.94 %)

SPY $ 529.09 $ 6.48 (1.24 %)

TLT $ 92.14 $ 1.24 (1.36 %)

GLD $ 220.89 $ 2.80 (1.28 %)

Previous Close

$ 37.08

Open

$ 39.78

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 36.89 - $ 40.08

52 Week Range

$ 13.53 - $ 62.21

Volume

1,011,263

Average Volume

Market Cap

2.53B

Beta (5Y Monthly)

$ 1.82

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	07-31-2023	06-30-2023	10-Q
5	05-12-2023	03-31-2023	10-Q
6	03-23-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

sony-group-posts-upbeat-earnings-joins-gamestop-paysafe-and-other-big-stocks-moving-higher-on-tuesday

Sony Group Posts Upbeat Earnings, Joins Ga...
05/14/2024 15:01:34

crocs-to-rally-around-19-here-are-10-top-analyst-forecasts-for-monday

Crocs To Rally Around 19%? Here Are 10 Top...
05/13/2024 12:31:26

HC Wainwright & Co. Maintains Buy on Bioha...
05/13/2024 11:52:02

HC Wainwright & Co. analyst Douglas Tsao maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $63 ...

Biohaven On Thursday Reported Q1 2024 Adj....
05/10/2024 14:22:16

around-1m-bet-on-biohaven-check-out-these-4-stocks-insiders-are-buying

Around $1M Bet On Biohaven? Check Out Thes...
04/26/2024 11:36:41

UBS Maintains Buy on Biohaven, Raises Pric...
04/23/2024 15:40:55

UBS analyst Ashwani Verma maintains Biohaven (NYSE:BHVN) with a Buy and raises the price target from $59 to $60.

Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 13:51:23

Cantor Fitzgerald analyst Charles Duncan reiterates Biohaven (NYSE:BHVN) with a Overweight.

Biohaven Reports Pricing Of Public Offerin...
04/18/2024 10:02:11

The gross proceeds from the offering are expected to be approximately $230 million before deducting underwriting discounts and ...

Biohaven Announces $200M Public Offering O...
04/17/2024 20:15:35

Biohaven Ltd. (NYSE:BHVN), a biopharmaceutical company focused on the discovery, development and commercialization of life-chan...

why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ultragenyx Pharmaceutical Shares Are T...
04/15/2024 18:11:35

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

Reported Saturday, Biohaven Showcased Inno...
04/15/2024 06:18:30

Biohaven's first-in-class Molecular Degrader of Extracellular Proteins (MoDE™) technology targeting IgG removal, BHV-1300...

Cantor Fitzgerald Reiterates Overweight on...
04/10/2024 17:28:02

Cantor Fitzgerald analyst Charles Duncan reiterates Biohaven (NYSE:BHVN) with a Overweight.

RBC Capital Reiterates Outperform on Bioha...
04/09/2024 13:17:16

RBC Capital analyst Leonid Timashev reiterates Biohaven (NYSE:BHVN) with a Outperform and maintains $61 price target.

why-is-obesity-drug-developer-altimmune-stock-trading-lower-on-wednesday

Why Is Obesity Drug Developer Altimmune St...
03/27/2024 13:31:39

Latest findings on Altimmune's pemvidutide on body composition: lean mass preservation, significant weight loss from adipos...

obesity-drug-landscape-has-a-contender-from-biohaven-ceo-highlights-different-approach-amid-stiff-competition-from-novo-nordisk-eli-lilly

Obesity Drug Landscape Has A Contender Fro...
03/26/2024 17:48:38

Biohaven's approach to combat obesity. Learn about their experimental drug taldefgrobep alfa (t-alpha), targeting muscle gr...

HC Wainwright & Co. Maintains Buy on Bioha...
03/04/2024 11:35:04

HC Wainwright & Co. analyst Douglas Tsao maintains Biohaven (NYSE:BHVN) with a Buy and raises the price target from $50 ...

RBC Capital Maintains Outperform on Biohav...
03/01/2024 14:56:40

RBC Capital analyst Leonid Timashev maintains Biohaven (NYSE:BHVN) with a Outperform and lowers the price target from $62 to...

TD Cowen Maintains Outperform on Biohaven,...
03/01/2024 13:39:04

TD Cowen analyst Tyler Van Buren maintains Biohaven (NYSE:BHVN) with a Outperform and raises the price target from $35 to $55.

Biohaven Q4 EPS $(1.61) Down From $(1.27) YoY
02/29/2024 21:28:24

Biohaven (NYSE:BHVN) reported quarterly losses of $(1.61) per share. This is a 26.77 percent decrease over losses of $(1.27) pe...

this-analyst-is-bullish-on-biohavens-approach-in-neuro-psych-space

This Analyst Is Bullish On Biohaven's Appr...
02/16/2024 18:58:46

Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion acro...